Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota

The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments

(2016) Mohammad H Farzaei et al.   Journal of Neurogastroenterology and Motility

Review article: potential mechanisms of action of rifaximin in the management of irritable bowel syndrome with diarrhoea

(2015) M. Pimentel   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth

(2014) Aikaterini Pistiki et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Rifaximin: beyond the traditional antibiotic activity

(2014) Fiorella Calanni et al.   JOURNAL OF ANTIBIOTICS

Are There Any Different Effects of Bifidobacterium, Lactobacillus and Streptococcus on Intestinal Sensation, Barrier Function and Intestinal Immunity in PI-IBS Mouse Model?

(2014) Huan Wang et al.   PLoS One

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

(2013) Dabo Xu et al.   GASTROENTEROLOGY

Mucosal Mast Cell Count Is Associated With Intestinal Permeability in Patients With Diarrhea Predominant Irritable Bowel Syndrome

(2013) Hyuk Lee et al.   Journal of Neurogastroenterology and Motility

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

(2012) P. Meyrat et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome

(2012) J. Matricon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

(2012) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff

(2012) S. Ludidi et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

(2012) I. M. Carroll et al.   NEUROGASTROENTEROLOGY AND MOTILITY

The SILVA ribosomal RNA gene database project: improved data processing and web-based tools

(2012) Christian Quast et al.   NUCLEIC ACIDS RESEARCH

Pregnane X receptor as a target for treatment of inflammatory bowel disorders

(2012) Jie Cheng et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome

(2012) Robin Spiller et al.   Journal of Neurogastroenterology and Motility

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota

(2011) Ian B Jeffery et al.   GUT

Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review

(2011) Alexander C. Ford et al.   JOURNAL OF GASTROENTEROLOGY

Characteristics of intestinal lamina propria dendritic cells in a mouse model of postinfectious irritable bowel syndrome

(2011) Yanqin Long et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifaximin in the treatment of inflammatory bowel disease

(2011) Mario Guslandi   WORLD JOURNAL OF GASTROENTEROLOGY

Th17 Cytokines and the Gut Mucosal Barrier

(2010) Christoph Blaschitz et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Systematic review of animal models of post-infectious/post-inflammatory irritable bowel syndrome

(2010) Hong-Yan Qin et al.   JOURNAL OF GASTROENTEROLOGY

Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation

(2010) J. Cheng et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The Relationship Between Intestinal Microbiota and the Central Nervous System in Normal Gastrointestinal Function and Disease

(2009) Stephen M. Collins et al.   GASTROENTEROLOGY

Postinfectious Irritable Bowel Syndrome

(2009) Robin Spiller et al.   GASTROENTEROLOGY

Th17: A New Participant in Gut Dysfunction in Mice Infected withTrichinella spiralis

(2009) Yu Fu et al.   MEDIATORS OF INFLAMMATION

Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome

(2009) QiQi Zhou et al.   PAIN

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators

(2008) T Piche et al.   GUT